News
APUS
1.510
+10.22%
0.140
Apimeds Pharmaceuticals Delays Quarterly SEC Filing
TipRanks · 1d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 5d ago
Weekly Report: what happened at APUS last week (0504-0508)?
Weekly Report · 5d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 05/07 17:05
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 05/06 17:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 05/06 12:06
Why Veeco Instruments Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
Benzinga · 05/06 09:16
Apimeds Pharmaceuticals US Settles All Resolving Disputes With Inscobee Regarding Apimeds Business Combination With MindWave Innovations
Benzinga · 05/05 19:11
Press Release: Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
Dow Jones · 05/05 19:06
*Apimeds Pharmaceuticals US: Lokahi to Deliver $4M Within Five Business Days Following Effective Date of Settlement
Dow Jones · 05/05 18:11
*Apimeds Pharmaceuticals US: Lokahi Therapeutics to Advance Apitox Program >APUS
Dow Jones · 05/05 18:10
*Apimeds Pharmaceuticals US: $100M PIPE Financing to Close
Dow Jones · 05/05 18:09
*Apimeds Pharmaceuticals US Settles With Inscobee
Dow Jones · 05/05 18:08
*Apimeds Pharmaceuticals US: MindWave Innovations Merger to Proceed
Dow Jones · 05/05 18:08
Apimeds Names Sungjoon Chae Co-Chief Executive Officer
TipRanks · 05/05 16:58
Apimeds Pharmaceuticals Appoints Sungjoon Chae Co-CEO, Effective May 4
Benzinga · 05/05 16:38
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
Barchart · 05/05 13:07
Apimeds Pharmaceuticals Q4 EPS $(0.80) Down From $(0.50) YoY
Benzinga · 05/04 13:36
Apimeds Secures Forbearance to Support Listing Remediation
TipRanks · 05/04 10:50
Weekly Report: what happened at APUS last week (0427-0501)?
Weekly Report · 05/04 09:42
More
Webull provides a variety of real-time APUS stock news. You can receive the latest news about APIMEDS PHARMACEUTICALS US INC through multiple platforms. This information may help you make smarter investment decisions.
About APUS
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.